Quick Answer
Lexeo Therapeutics, Inc. reported Total Assets of $268.69 million for the year ending 2025.
- Lexeo Therapeutics, Inc. showed an increase of +82.9% in Total Assets from 2024 to 2025.
- This data is from Lexeo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $54.72 million | Q1 2024: $213.21 million | Q2 2024: $192.01 million | Q3 2024: $173.87 million | Q1 2025: $125.69 million | Q2 2025: $176.07 million | Q3 2025: $143.84 million.
- Over the full 4 years of available data (2022 to 2025), Lexeo Therapeutics, Inc.'s Total Assets has grown by 176.8%.
- Historical annual values: Fiscal year 2025: $268.69 million | Fiscal year 2024: $146.94 million | Fiscal year 2023: $139.81 million | Fiscal year 2022: $97.08 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: